Submit your letter of intent to the MATWIN programme before June 17th 2016!
You have identified an innovation in oncology and are willing to promote it to ensure the best possible chance of success. MATWIN, a nationwide service platform that supports the maturation of innovative research projects in oncology will offer you the opportunity to benefit from:
– International assessments (academics and industrials)
– Specific coaching to get a better structured project and therefore optimize its transfer potential
– Best projects submitted to an international Board of experts gathering the biggest pharma companies involved in oncology
The MATWIN label will ensure the project excellence and industrial attractiveness.
- Why should you apply ?
MATWIN is supported by twelve of the world’s largest pharmaceutical companies involved in the fight against cancer (Amgen, AstraZeneca, Bayer HealthCare, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Novartis, Pfizer, Pierre Fabre, Roche, and Sanofi) and by the French Cancéropôles.MATWIN identifies world-class projects in France, increases their industrial attractiveness and optimizes their transfer potential for the benefit of patients.
More information on https://www.matwin.fr/?lg=en
- Who can apply ?
As encouraged through the 3rd French Cancer Plan, a special attention will be given to projects offering innovations in diagnostic or therapeutic for pediatric cancers (childs or young adults)
- How to apply ?
Contact: email@example.com – 0033 5 35 54 19 36 – 0033 6 84 01 61 70